Hangzhou AllTest Biotech CO.,LTD 

      Your Reliable Rapid Test Partner!

Home
Products
About Us
Factory Tour
Quality Control
Contact Us
Request A Quote
News
Home News

SARS-CoV-2 Cycle Threshold: A Metric That Matters (or Not)

I'm Online Chat Now
China Hangzhou AllTest Biotech CO.,LTD certification
China Hangzhou AllTest Biotech CO.,LTD certification
I like the products and service provided by AllTest. They really take our interest into consideration.

—— Mr John Smith England

My oldest daughter actually has Lyme disease. She spent almost 1 year in a wheelchair because of Lyme. She is doing very well now. I used 2 of the samples. 1 to test my Lyme diagnosed daughter and 1 to test my daughter who does not have Lyme. Your tests worked well. My daughter with Lyme tested positive and the one who does not tested negative.

—— Ms Sheila

Whenever I have the requests,AllTest always give me the satisfied reply at the first time.

—— Mrs Julie Tschetter Belgium

As the old customer of AllTest since 2009, we should thank the great work have been done by AllTest to support us gain more market share and profit

—— Mr Robin Seifert Germany

Company News
SARS-CoV-2 Cycle Threshold: A Metric That Matters (or Not)
Latest company news about SARS-CoV-2 Cycle Threshold: A Metric That Matters (or Not)

Growing evidence suggests Ct marks severe COVID-19 illness, but with few quantitative assays, lack of standardization across tests, labs shy from routinely reporting this value.

The cycle threshold (Ct) in reverse transcription polymerase chain reaction (RT-PCR) SARS-CoV-2 tests is gaining currency as a potential marker for severe disease in patients with COVID-19 illness. Amid mounting evidence in the clinical literature, however, some in the laboratory community are urging caution about the utility of this metric, how and even if it should be reported.

Ct refers to the number of cycles needed to amplify viral RNA to reach a detectable level. Certain testing platforms reveal Ct, but labs generally don’t provide the Ct value when reporting test results. It’s unclear how Ct should be applied in clinical settings. No standardization for Ct values exists across RT-PCR platforms, making it difficult to compare results among different tests. Researchers in clinical studies also haven’t validated using Ct to guide management of COVID-19 cases.

Several studies, however, point to a telling link between this viral load marker and severity of disease.

One review published in July in Infectious Diseases and Therapy reported an association between lower Ct values and not only worsening disease but also progression to severe disease and complications. Examining data from 18 studies, the investigators found significant correlations between Ct values and severe disease or death, as well as Ct and the presence of biochemical and hematological markers.

SEE MORE DETAIL ABOUT COVID-19 RAPID TEST AND RT-PCR:

http://www.alltests.com.cn/

Pub Time : 2021-04-29 16:55:17 >> News list
Contact Details
Hangzhou AllTest Biotech CO.,LTD

Contact Person: Mrs. Selina

Tel: +86 13989889852

Fax: 86-571-56267856

Send your inquiry directly to us